We are live on ! Find out more
PARS

PHARMOS CORP NEW
PARS

Delisted

PARS was delisted on the 12th of March, 2009.

Back to rankings

1 hedge funds and large institutions have $3 invested in PHARMOS CORP NEW in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AWA
Arkadios Wealth Advisors
Georgia
+$3

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AWA
1
Arkadios Wealth Advisors
Georgia
$3 +$3 +400 New

PARS Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in PHARMOS CORP NEW (PARS) for Q1 2020, worth a combined $3.

Buyers outnumbered sellers: 1 fund opened new PARS positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Arkadios Wealth Advisors, opening a new position worth an estimated $3.

  • 1 institutional investor held PHARMOS CORP NEW (PARS) as of Q1 2020, up from 0 in Q4 2019.
  • Funds reported $3 of PHARMOS CORP NEW stock for Q1 2020.
  • 1 fund opened new PHARMOS CORP NEW positions in Q1 2020 and 0 closed out, a net change of +1 holder.
  • The largest PHARMOS CORP NEW buyer in Q1 2020 was Arkadios Wealth Advisors, an estimated $3 added.

Based on aggregated 13F filings for Q1 2020.